|
| A new class of radiosensitizers for glioblastoma |
|
https://doi.org/10.18632/oncotarget.27970
Roger Abounader, David Schiff
|
| 1199-1200 |
|
| A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection |
|
https://doi.org/10.18632/oncotarget.27982
Shay Sharon, Jason R. Baird, Shelly Bambina, Gwen Kramer, Tiffany C. Blair, Shawn M. Jensen, Rom S. Leidner, R. Bryan Bell, Nardy Casap, Marka R. Crittenden, Michael J. Gough
|
| 1201-1213 |
|
| Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27992
Catherine T. Haring, Chandan Bhambhani, Collin Brummel, Brittany Jewell, Emily Bellile, Molly E. Heft Neal, Erin Sandford, Ryan M. Spengler, Apurva Bhangale, Matthew E. Spector, Jonathan McHugh, Mark E. Prince, Michelle Mierzwa, Francis P. Worden, Muneesh Tewari, Paul L. Swiecicki, J. Chad Brenner
|
| 1214-1229 |
|
| Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study |
|
https://doi.org/10.18632/oncotarget.27991
Anjali Gupta, Taofik Oyekunle, Omolola Salako, Adetola Daramola, Olusegun Alatise, Gabriel Ogun, Adewale Adeniyi, April Deveaux, Veeral Saraiya, Allison Hall, Omobolaji Ayandipo, Thomas Olajide, Olalekan Olasehinde, Olukayode Arowolo, Adewale Adisa, Oludolapo Afuwape, Aralola Olusanya, Aderemi Adegoke, Trygve O. Tollefsbol, Donna Arnett, Michael J. Muehlbauer, Christopher B. Newgard, Tomi Akinyemiju
|
| 1230-1242 |
|
| Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells |
|
https://doi.org/10.18632/oncotarget.27989
Andrew E. Greenstein, Hazel J. Hunt
|
| 1243-1255 |
|
| Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target |
|
https://doi.org/10.18632/oncotarget.27981
Natsumi Hayashi, Akitaka Yamasaki, Shiho Ueda, Shogo Okazaki, Yoshiya Ohno, Toshiyuki Tanaka, Yuichi Endo, Yoshihisa Tomioka, Kazue Masuko, Takashi Masuko, Reiko Sugiura
|
| 1256-1270 |
|
| TERT and its binding protein: overexpression of GABPA/B in high grade gliomas |
|
https://doi.org/10.18632/oncotarget.27985
Efthymios Papazacharias, Saskia Kuhl, Gabriele Röhn, Lukas Görtz, Roland Goldbrunner, Marco Timmer
|
| 1271-1280 |
|
| Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy |
|
https://doi.org/10.18632/oncotarget.27990
Annachiara Mollace, Maria Laura Coluccio, Giuseppe Donato, Vincenzo Mollace, Natalia Malara
|
| 1281-1295 |
|
| Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors |
|
https://doi.org/10.18632/oncotarget.27988
Shilpa S. Dhar, Min Gyu Lee
|
| 1296-1308 |
|
| Targeting super-enhancers reprograms glioblastoma central carbon metabolism |
|
https://doi.org/10.18632/oncotarget.27938
Trang T.T. Nguyen, Mike-Andrew Westhoff, Georg Karpel-Massler, Markus D. Siegelin
|
| 1309-1313 |
|
| Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.27919
Jan Philipp Bewersdorf, Amer M. Zeidan
|
| 1314-1317 |
|
| The formation of pre-effectors in the steady state opens a new perspective for cancer immunosurveillance |
|
https://doi.org/10.18632/oncotarget.27967
Alexey Surnov, Daniel Hawiger
|
| 1318-1320 |
|
| Mechanisms of gefitinib-induced interstitial pneumonitis: why and how the TKI perturbs innate immune systems? |
|
https://doi.org/10.18632/oncotarget.27958
Tomohiro Kagi, Takuya Noguchi, Atsushi Matsuzawa
|
| 1321-1322 |
|
| Correction: BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
|
https://doi.org/10.18632/oncotarget.28001
M. Herman Chui, Susanne K. Kjaer, Kirsten Frederiksen, Charlotte G. Hannibal, Tian-Li Wang, Russell Vang, Ie-Ming Shih
|
| 1323-1324 |
|
| Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.28004
Edna Gordian, Eric A. Welsh, Nicholas Gimbrone, Erin M. Siegel, David Shibata, Ben C. Creelan, William Douglas Cress, Steven A. Eschrich, Eric B. Haura, Teresita Muñoz-Antonia
|
| 1325-1325 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
